Kava kava
Best for
Lower day-to-day anxiety
Proven but unnoticeable · 300 mg/day for 4–13 weeks · 1 meta-analysis , n=585
3 papers · 3 claims · 2 outcomes scored · 3 positive
Outcomes
What kava kava actually does, by outcome
Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.
The background hum of worry that colors everything gets quieter.
Quiets the health worries and body tension that build with age.
| Outcome | Effect | Evidence | Dose | Weeks | Rank |
|---|---|---|---|---|---|
| Lower day-to-day anxiety Proven but unnoticeable | | 2 meta-analyses n=585 Meta-analyzed | 300 mg | 4–13 wk | #5/48 |
| Ease anxiety in older adults Proven but unnoticeable | | 2 meta-analyses n=585 Meta-analyzed | 300 mg | 4–13 wk | #5/45 |
| Reduce pre-competition anxiety Proven but unnoticeable | | 2 meta-analyses n=585 Meta-analyzed | 300 mg | 4–13 wk | #5/45 |
Risk profile
Adverse events and known drug interactions
Safety events
Drug interactions
Sources
- 1. Kava extract for treating anxiety. (2003) ↑
- 2. An internet-based randomized, placebo-controlled trial of kava and valerian for anxiety and insomnia. (2005) ↑
- 3. Neuroimaging Insights: Kava's (Piper methysticum) Effect on Dorsal Anterior Cingulate Cortex GABA in Generalized Anxiety Disorder. (2023) ↑
Generated August 14, 2026
Related
More evidence for Kava kava
Ranking
Day-to-day anxiety
NewBest Supplements for Anxiety, Ranked by Clinical Evidence
Evidence ranking
Apr 4, 2026
Evidence map
Stress
NewStress: evidence map across 46 supplements
Evidence coverage map
Jul 30, 2026
Ingredient evidence
Ingredient evidence
New5-HTP
All scored outcomes
Aug 14, 2026
Ingredient evidence
Ingredient evidence
NewAshwagandha
All scored outcomes
Aug 14, 2026
Ingredient evidence
Ingredient evidence
NewBergamot (Citrus bergamia)
All scored outcomes
Aug 14, 2026
Ingredient evidence
Ingredient evidence
NewCaffeine
All scored outcomes
Aug 14, 2026